NASDAQ:SABS

SAB Biotherapeutics, Inc.

Stock

USD

Last Close

2.76

26/07 20:00

Market Cap

29.53M

Beta: 1.26

Volume Today

2.99K

Avg: 1.39M

PE Ratio

−10.36

PFCF: 7.38

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	3.44M -	55.24M 1,504.91%	60.88M 10.21%	23.90M 60.73%	2.24M 90.63%
cost of revenue			1.65M -	3.29M 99.07%	3.75M 13.77%
gross profit	3.44M -	55.24M 1,504.91%	59.22M 7.21%	20.61M 65.20%	-1.51M 107.31%
selling and marketing expenses					-3.75M -
general and administrative expenses	4.10M -	6.77M 65.35%	17.09M 152.29%	16.38M 4.11%	23.80M 45.27%
selling general and administrative expenses	4.10M -	6.77M 65.35%	17.09M 152.29%	16.38M 4.11%	20.05M 22.41%
research and development expenses	8.02M -	27.91M 248.00%	57.18M 104.90%	36.44M 36.28%	16.52M 54.68%
other expenses	2.59K -	4.00K 54.05%	-60.88M 1,523,525.38%	-23.90M 60.73%
cost and expenses	12.12M -	34.68M 186.26%	13.39M 61.38%	28.92M 115.91%	40.31M 39.41%
operating expenses	12.12M -	34.68M 186.26%	13.39M 61.38%	28.92M 115.91%	36.57M 26.46%
interest expense	428.48K -	469.15K 9.49%	294.46K 37.24%	301.58K 2.42%	-315.28K 204.54%
ebitda	-8.23M -	21.14M 356.67%	-11.71M 155.41%	-27.16M 131.91%	-34.33M 26.40%
operating income	-8.67M -	20.56M 337.01%	-13.39M 165.15%	-28.92M 115.91%	-38.08M 31.67%
depreciation and amortization	439.13K -	578.30K 31.69%	1.68M 190.88%	1.76M 4.53%	3.75M 112.99%
total other income expenses net	-312.75K -	-439.02K 40.38%	-3.75M 754.47%	10.20M 371.97%	-4.12M 140.37%
income before tax	-8.99M -	20.12M 323.87%	-17.14M 185.22%	-18.72M 9.16%	-42.19M 125.45%
income tax expense	431.07K -	473.15K 9.76%	299.95K 36.61%	25.63K 91.46%	-2 100.01%
net income	-9.42M -	20.12M 313.62%	-17.44M 186.71%	-18.74M 7.43%	-42.19M 125.14%
weighted average shs out	43.47M -	2.54M 94.16%	2.73M 7.67%	4.35M 59.20%	5.52M 26.86%
weighted average shs out dil	43.47M -	2.70M 93.79%	2.73M 1.21%	4.35M 59.20%	5.52M 26.86%
eps	-0.22 -	7.92 3,700%	-6.38 180.56%	-4.31 32.45%	-7.64 77.26%
epsdiluted	-0.22 -	7.45 3,486.36%	-6.38 185.64%	-4.31 32.45%	-7.64 77.26%

All numbers in USD (except ratios and percentages)